1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B39B691B012DFB9400258730003401B5
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-leveraging-outcomes-data-structure-collaboration-health-economics-outcomes-research-cns-products?opendocument
18
19opendocument
203.239.58.199
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Health Outcomes

Leveraging Outcomes Data - Structure and Collaboration in Health Economics & Outcomes Research for CNS Products

ID: 5690


Features:

4 Info Graphics

18 Data Graphics

390+ Metrics


Pages/Slides: 29


Published: 2021


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Leveraging Outcomes Data - Structure and Collaboration in Health Economics & Outcomes Research for CNS Products”

STUDY OVERVIEW

To gain market access and market share in the CNS marketplace, it is important for pharma companies to demonstrate the CNS product’s value proposition and its potential based on real-world clinical practice.

The Health Economics Outcomes Research (HEOR) function is a significant player in generating value-oriented outcomes data, but success revolves around effective collaboration with other groups to leverage information across the organization.

Best Practices, LLC conducted this benchmarking research to identify how leading CNS manufacturers develop successful Health Outcomes groups. This study illustrates the strategies for effective health outcomes data communication and utilization and how HEOR collaborates with key internal stakeholders.

Study insights are further segmented based on the HEOR reporting structure.

KEY TOPICS

  • CNS HEOR group structure
  • HEOR involvement and its effectiveness in delivering value
  • Health outcomes data usage and its effectiveness
  • Role of HEOR in health outcomes activities and data collection

KEY METRICS
  • Where does the Health Economics and Outcomes Research (HEOR) group sit within the organization?
  • Which of the listed decisions does the HEOR function lead, support, has no involvement in, or plan to participate in the next 12 months?
  • How effective is the HEOR function at delivering value in the listed areas to the company?
  • Which of the listed types of Health Outcomes data does your HEOR function utilize?
  • How effective is the Health Outcomes data to inform key decisions within the company?
  • Please indicate the level of your organization’s HEOR involvement in each of the listed activities
  • With which groups is the medical information being shared?
  • What is the organization’s role in collecting the listed Health Outcomes data?
  • What is the preferred frequency of communications (at a country & region level) with internal staff?
  • What roles do HEOR teams play in carrying out activities designed to probe (payers) stakeholders’ needs and perspectives?

SAMPLE KEY FINDINGS
  • HEOR Effectiveness for Delivering Value: In CNS, pricing and health outcomes research are critical value drivers led by HEOR functions.

METHODOLOGY

Best Practices, LLC engaged 16 executives from 14 pharmaceuticals offering CNS products. The study insights are mostly from directors and higher management executives, representing around ninety percent of the participants. Functional segments in the study will help pinpoint differences in value delivery among Medical Affairs and Commercial HEOR groups.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Biopharmaceutical; Communications


Companies Profiled:
AbbVie; Alexion Pharmaceuticals; Bayer; Brii Biosciences; CSL Behring; Eisai; Greenwich Biosciences; Harmony Biosciences; Lundbeck; Merck; Novartis; Nucleus Global; Pfizer; Takeda Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.